drugset / Trial / NCT01761149

Effect of Higher Doses of Remifentanil on Postoperative Pain in Patients Undergoing Thyroidectomy

NCT01761149 ↗

Phase 4 Unknown 60 enrolled Central South University
RandomizedParallel-groupDouble-blindTreatment

Summary

Extensive clinical studies have shown that intraoperative infusion high dose of remifentanil (0.2ug/kg/min) induced postoperative hyperalgesia. Recent experimental study however suggests that higher dose of remifentanil may attenuate postoperative hyperalgesia. Thus, the present study is designed as a "proof of principle" study and hypothesizes that higher dose of remifentanil may reduce postoperative pain in patients.

Timeline

Start
2012-12
Primary completion
2013-03
Completion
—

Outcome

Met primary endpoint

paper Postoperative morphine consumption was much lower in the HD group compared with the RD group (1.27 ± 1.88 mg vs. 0.35 ± 1.25 mg, p = 0.033). PMID 24667391 ↗

paper VAS scores were lower 30 min postoperatively in the HD group PMID 24667391 ↗

paper (t = 3.427, p = 0.0043, RD group vs. HD group). PMID 24667391 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 0.2 ug/kg —
Subject Remifentanil Small molecule 1.2 ug/kg —

Indications